Programmed death ligand 2 – A link between inflammation and bone loss in rheumatoid arthritis
Open Access
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Journal of Translational Autoimmunity
- Vol. 3, 100028
Abstract
No abstract availableKeywords
Funding Information
- Aarhus Universitet
- Velux Fonden
- Gigtforeningen
- National Institutes of Health
This publication has 44 references indexed in Scilit:
- Elimination of erroneous results in flow cytometry caused by antibody binding to Fc receptors on human monocytes and macrophagesCytometry Part A, 2016
- A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavageOncoImmunology, 2015
- OsteoRheumatology: a new discipline?RMD Open, 2015
- The PD-1/PD-Ls pathway and autoimmune diseasesCellular Immunology, 2014
- A simple set of validation steps identifies and removes false results in a sandwich enzyme-linked immunosorbent assay caused by anti-animal IgG antibodies in plasma from arthritis patientsSpringerPlus, 2013
- Neogenin, a Receptor for Bone Morphogenetic ProteinsJournal of Biological Chemistry, 2011
- The programmed death 1/programmed death ligand 1 inhibitory pathway is up‐regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritisArthritis & Rheumatism, 2010
- Cell-cell Interactions in Rheumatoid Arthritis SynoviumRheumatic Disease Clinics of North America, 2010
- Regulatory T cells (Treg) in rheumatoid arthritisJoint Bone Spine, 2009
- Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systemsNature Reviews Immunology, 2007